|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
University of Cambridge > Talks.cam > The obesity epidemic: Discussing the global health crisis > Commodotech' Profits Verses Human & Environmental Health' - Enough Biology - Time for Political Action on Global 'Obesity' Crisis Solutions
Commodotech' Profits Verses Human & Environmental Health' - Enough Biology - Time for Political Action on Global 'Obesity' Crisis Solutions
If you have a question about this talk, please contact Ilana Spilka.
Traditional western approaches to obesity include blaming individuals for their ‘gluttony & sloth’ – ridicule and judgement of those with such ‘obvious’ differences. In the 1990’s select medical biochemistry and genetic research followed, showing some cytokine (eg leptin) effects on energy – fat metabolism, energy sensing and appetite control. Emphases switched to commodity technology (commodotech)-based medical research (chemical/machine/electronics) & practice (pharmaceuticals/devices). Human evolutionary, ecological biology reveals drives to acquire energy plus specific requirements for plant-food micronutrition for healthy development & longevity. Enough real scientific evidence means politics of commodotech profits verses human and environmental health is the issue to address.
This talk is part of the The obesity epidemic: Discussing the global health crisis series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsInstitute of Metabolic Science Seminars Centre for Risk Studies - talks & events Meeting the Challenge of Healthy Ageing in the 21st Century
Other talksWithin-host spatiotemporal dynamics of systemic Salmonella infection during and after antibiotic treatment DIAL 1st year PhD student trial presentations The Emergence of the Sovereign Consumer – from Adam Smith to the Socialist Calculation Debate Mexico (in 3D) '"Chantez la vie, l'amour, et la mort": the French 'chanson' in context' Dr David Komander: Studying non-existent ubiquitin chains